These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1283763)

  • 21. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM; Dowse GK; Zimmet PZ
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance: trigger or concomitant factor in the metabolic syndrome.
    Avogaro A
    Panminerva Med; 2006 Mar; 48(1):3-12. PubMed ID: 16633326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome?
    Nisoli E; Clementi E; Carruba MO; Moncada S
    Circ Res; 2007 Mar; 100(6):795-806. PubMed ID: 17395885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The metabolic syndrome].
    Internist (Berl); 1995 May; 36(5 Suppl Metabolisc):1-12. PubMed ID: 9403089
    [No Abstract]   [Full Text] [Related]  

  • 26. Obesity, weight loss, and cardiovascular health: is oxidative capacity a missing link?
    Phillips SA
    Am J Hypertens; 2008 Dec; 21(12):1277. PubMed ID: 19020508
    [No Abstract]   [Full Text] [Related]  

  • 27. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of "syndrome X".
    Resnick LM
    Am J Hypertens; 1993 Apr; 6(4):123S-134S. PubMed ID: 8507440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin resistance and the coronary syndrome].
    Okapcová J; Hrnciar J; Kovár F; Kurray P; Gábor D; Lepej J
    Vnitr Lek; 1999 Jan; 45(1):3-10. PubMed ID: 10422519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment of glucose tolerance: mechanism of action and impact on the cardiovascular system.
    Beck-Nielsen H; Hother Nielsen O; Damsbo P; Vaag A; Handberg A; Henriksen JE
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):292-5. PubMed ID: 2115296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?
    Laakso M
    Curr Diab Rep; 2015 Dec; 15(12):105. PubMed ID: 26458376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome.
    Hjermann I
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S5-10. PubMed ID: 1283771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease.
    Rask-Madsen C; Kahn CR
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2052-9. PubMed ID: 22895666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic abnormalities in hypertension.
    Afonso LC; Edelson GW; Sowers JR
    Curr Opin Nephrol Hypertens; 1997 May; 6(3):219-23. PubMed ID: 9263663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids and insulin resistance: old hormones, new targets.
    Andrews RC; Walker BR
    Clin Sci (Lond); 1999 May; 96(5):513-23. PubMed ID: 10209084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective.
    Conte M; Franceschi C; Sandri M; Salvioli S
    Trends Endocrinol Metab; 2016 Dec; 27(12):893-903. PubMed ID: 27659144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Background of cardiovascular diseases in adult--with special reference to metabolic disorder of glucose and hypertension].
    Iimura O
    Nihon Ronen Igakkai Zasshi; 1994 Jan; 31(1):1-9. PubMed ID: 8158864
    [No Abstract]   [Full Text] [Related]  

  • 37. Scaffold Proteins: From Coordinating Signaling Pathways to Metabolic Regulation.
    Mugabo Y; Lim GE
    Endocrinology; 2018 Nov; 159(11):3615-3630. PubMed ID: 30204866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic errors and sudden deafness.
    Currier WD
    Otolaryngol Clin North Am; 1975 Jun; 8(2):501-5. PubMed ID: 1153213
    [No Abstract]   [Full Text] [Related]  

  • 39. States of insulin resistance: the interaction between hypertension, glucose intolerance, and coronary heart disease. Proceedings of a symposium. Montreal, Canada, June 24, 1990.
    Am Heart J; 1991 Apr; 121(4 Pt 2):1267-318. PubMed ID: 1672574
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular Aspects of Cardiometabolic Diseases: From Etiopathogenesis to Potential Therapeutic Targets.
    Bernatova I; Bartekova M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.